Mesothelioma - Mesothelioma Asbestos Lung Cancer Information

Mesothelioma - Mesothelioma Asbestos Lung Cancer Information

Articles & News on Desmoplastic Mesothelioma


>
>
Home
Link to us
> Mesothelioma Information
Mesothelioma of Pleura
Peritoneal Mesothelioma
Symptoms
Diagnosis
Staging
Mesothelioma Lung Cancer Pictures
Pleural Effusion
> Treatment Options
 Medical Procedures
 Drugs / Medications
 - Information on Alimta
Find a Doctor
Clinical Trials
Hospitals
Support
> Coping Strategy
What to Do
Financial Recovery
Who Can Help
Mesothelioma Lawyer Information
> What Caused Mesothelioma
Where was I Exposed
Asbestos FAQs
Hazardous Jobs
> Articles & News
Medical News
Survivors Stories
Legislation & Breaking News
Articles on Treatment Options

>

Our resources

 

Articles on Treatment Options

Back to Articles Index Page

Intestinal obstruction due to diffuse peritoneal fibrosis at 2 years after the successful treatment of malignant peritoneal mesothelioma with intraperitoneal mitoxantrone [published erratum appears in Cancer Chemother Pharmacol 1992;30(3):249]

Abstract: A 44-year-old man who had achieved a complete remission of malignant peritoneal mesothelioma after the intraperitoneal administration of 25mg/m2 mitoxantrone presented with clinical and radiological signs of intestinal obstruction suggestive of recurrent disease at about 2 years following the initial treatment. However, laparotomy revealed extensive adhesive fibrosis but no sign of malignant mesothelioma. The peritoneal complications of intraperitoneal cytostatic treatment are discussed.

Vlasveld LT and Taal BG
Department of Medical Oncology, The Netherlands Cancer Institute,
Antoni van Leeuwenhoek Huis, Amsterdam.
Cancer Chemother Pharmacol
1992, vol. 29, pages 405-408
GERMANY

Back to Articles Index Page